12 Best Low-Priced Pharma Stocks to Buy Right Now

10. Lifecore Biomedical, Inc. (NASDAQ:LFCR)

Number of Hedge Fund Holders: 17

Stock Price: $5.80

Lifecore Biomedical, Inc. (NASDAQ:LFCR) is one of the best low-priced pharma stocks on this list.

TheFly reported on June 16 that Barrington increased its price target on LFCR to $6.50 from $6.00 while reaffirming an Outperform rating on the shares. The firm’s updated outlook followed LFCR’s announcement of a new agreement with a global pharmaceutical company, marking its second such partnership within two weeks. Barrington noted that these agreements demonstrate the company’s ability to broaden its clinical development footprint while successfully advancing its long-term strategic objectives.

On June 15, Lifecore Biomedical, Inc. (NASDAQ:LFCR) disclosed a new agreement with a global pharmaceutical company under which it will provide technical transfer services for the commercial manufacturing of an injectable suspension therapy for neurological disorders. The contract represents the company’s seventh late-stage program agreement secured within the previous seven months, reflecting continued growth in its development pipeline. The selection also highlights LFCR’s expertise in manufacturing complex, high-viscosity injectable formulations and reinforces its position as a contract development and manufacturing partner for multinational pharmaceutical companies seeking specialized production capabilities in the United States.

Lifecore Biomedical, Inc. (NASDAQ:LFCR) is a contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceuticals, complex formulations, and injectable-grade hyaluronic acid production.

1281292 - 11759070 - 1